Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium cholate is the sodium salt of cholic acid, a primary bile acid synthesized from cholesterol in the liver. While traditionally recognized for its physiological role in the emulsification and absorption of dietary lipids, sodium cholate also functions as a signaling molecule that activates specific receptors, including the nuclear Farnesoid X receptor (FXR) and the membrane-bound G protein-coupled bile acid receptor 1 (TGR5/GPBAR1). These pathways are involved in the regulation of glucose metabolism, lipid homeostasis, and inflammatory responses. In a clinical research context led by the Second Xiangya Hospital of CSU, oral sodium cholate is being investigated as an immunomodulatory agent for patients with recent-onset type 1 diabetes mellitus. The therapeutic hypothesis suggests that sodium cholate may modulate pathogenic T cell populations, specifically reducing the frequency of CD226+ CD8+ T cells, thereby preserving residual pancreatic beta-cell function and improving glycemic control.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium cholate.